Skip to main content
Erschienen in: AIDS and Behavior 1/2012

01.01.2012 | Original Paper

Conversations With Mothers: Exploring Reasons for Prevention of Mother-to-Child Transmission (PMTCT) Failures in the Era of Programmatic Scale-Up in Soweto, South Africa

verfasst von: Fatima Laher, Angela Cescon, Erica Lazarus, Angela Kaida, Matamela Makongoza, Robert S. Hogg, Christine N. Soon, Cari L. Miller, Glenda Gray

Erschienen in: AIDS and Behavior | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

Reasons for incident cases of vertical HIV transmission in the era of free access to PMTCT in South Africa were investigated. This mixed-methods study was conducted in Soweto, South Africa from June–August, 2009. Birthmothers of HIV-infected infants born after 1 December 2008 were eligible. All participants completed an interviewer-administered questionnaire. Women also participated in a focus group (n = 10) or individual structured interview (n = 35). Mean age of participants (n = 45) was 28.7 years (SD = 5.4). Major findings are: (i) failure of per-guideline prescription of ARV strategies for infants (31%) and/or mothers (57%); (ii) maternal refusal of treatment (n = 5); (iii) preterm delivery (31%); (iv) delayed ANC attendance because of facility-related barriers and maternal apprehension around HIV testing; (v) fear of stigma; (vi) maternal difficulty with administering infant AZT (n = 9) and (vii) maternal confusion about infant feeding. A variety of individual, social, and structural factors must be addressed to optimize PMTCT service delivery in South Africa.
Literatur
1.
Zurück zum Zitat Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis. 2006;6(11):726–32.PubMedCrossRef Kourtis AP, Lee FK, Abrams EJ, Jamieson DJ, Bulterys M. Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis. 2006;6(11):726–32.PubMedCrossRef
3.
Zurück zum Zitat De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175–82. Mar 1.PubMedCrossRef De Cock KM, Fowler MG, Mercier E, et al. Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA. 2000;283(9):1175–82. Mar 1.PubMedCrossRef
4.
Zurück zum Zitat Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AIDS. 2002;29(5):484–94. Apr 15. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J AIDS. 2002;29(5):484–94. Apr 15.
6.
Zurück zum Zitat McIntyre J, Lallemant M. The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure? Curr Opin HIV AIDS. 2008;3(2):139–45.PubMedCrossRef McIntyre J, Lallemant M. The prevention of mother-to-child transmission of HIV: are we translating scientific success into programmatic failure? Curr Opin HIV AIDS. 2008;3(2):139–45.PubMedCrossRef
7.
Zurück zum Zitat World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2010 [cited 2010 8 August]. http://www.who.int/hiv/pub/mtct/. World Health Organisation. Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access: recommendations for a public health approach. 2010 [cited 2010 8 August]. http://​www.​who.​int/​hiv/​pub/​mtct/​.
9.
Zurück zum Zitat Barker P. Antiretroviral drugs in the cupboard are not enough: the importance of health systems’ performance on preventing mother-to-child transmission. In: 3rd South African AIDS conference 2009; Durban, South Africa; 2009. Abstract 550. Barker P. Antiretroviral drugs in the cupboard are not enough: the importance of health systems’ performance on preventing mother-to-child transmission. In: 3rd South African AIDS conference 2009; Durban, South Africa; 2009. Abstract 550.
11.
Zurück zum Zitat Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa’s mothers, babies, and children: can the health system deliver? Lancet. 2009;374(9692):835–46. Sep 5.PubMedCrossRef Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa’s mothers, babies, and children: can the health system deliver? Lancet. 2009;374(9692):835–46. Sep 5.PubMedCrossRef
14.
Zurück zum Zitat Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802. Sep 4.PubMedCrossRef Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet. 1999;354(9181):795–802. Sep 4.PubMedCrossRef
15.
Zurück zum Zitat Mnyani C, McIntyre J, Struthers H, et al. Reducing PMTCT in practice: results from a successful model of a PMTCT program in a high prevalence HIV urban African setting. In: 5th IAS conference on HIV pathogenesis, treatment and prevention, 19–22 July, Cape Town, South Africa; 2009. Mnyani C, McIntyre J, Struthers H, et al. Reducing PMTCT in practice: results from a successful model of a PMTCT program in a high prevalence HIV urban African setting. In: 5th IAS conference on HIV pathogenesis, treatment and prevention, 19–22 July, Cape Town, South Africa; 2009.
18.
Zurück zum Zitat Stringer EM, Ekouevi DK, Coetzee D, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304(3):293–302. Jul 21.PubMedCrossRef Stringer EM, Ekouevi DK, Coetzee D, et al. Coverage of nevirapine-based services to prevent mother-to-child HIV transmission in 4 African countries. JAMA. 2010;304(3):293–302. Jul 21.PubMedCrossRef
20.
Zurück zum Zitat Walker D, Myrick F. Grounded theory: an exploration of process and procedure. Qual Health Res. 2006;16(4):547–59.PubMedCrossRef Walker D, Myrick F. Grounded theory: an exploration of process and procedure. Qual Health Res. 2006;16(4):547–59.PubMedCrossRef
23.
Zurück zum Zitat Kebaabetswe PM. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaborone, Botswana a qualitative approach. AIDS Care. 2007;19(3):355–60.PubMedCrossRef Kebaabetswe PM. Barriers to participation in the prevention of mother-to-child HIV transmission program in Gaborone, Botswana a qualitative approach. AIDS Care. 2007;19(3):355–60.PubMedCrossRef
24.
Zurück zum Zitat Painter TM, Diaby KL, Matia DM, et al. Women’s reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ. 2004;329(7465):543.PubMedCrossRef Painter TM, Diaby KL, Matia DM, et al. Women’s reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study. BMJ. 2004;329(7465):543.PubMedCrossRef
25.
Zurück zum Zitat Dahl V, Mellhammar L, Bajunirwe F, Bjorkman P. Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal. AIDS Care. 2008;20(6):746–52.PubMedCrossRef Dahl V, Mellhammar L, Bajunirwe F, Bjorkman P. Acceptance of HIV testing among women attending antenatal care in south-western Uganda: risk factors and reasons for test refusal. AIDS Care. 2008;20(6):746–52.PubMedCrossRef
26.
Zurück zum Zitat Nkonki LL, Doherty TM, Hill Z, et al. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Res Ther. 2007;4:27.PubMedCrossRef Nkonki LL, Doherty TM, Hill Z, et al. Missed opportunities for participation in prevention of mother to child transmission programmes: simplicity of nevirapine does not necessarily lead to optimal uptake, a qualitative study. AIDS Res Ther. 2007;4:27.PubMedCrossRef
27.
Zurück zum Zitat Ellis J, Williams H, Graves W, Lindsay MK. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol. 2002;186(5):903–6.PubMedCrossRef Ellis J, Williams H, Graves W, Lindsay MK. Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome. Am J Obstet Gynecol. 2002;186(5):903–6.PubMedCrossRef
28.
Zurück zum Zitat Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):836–48.PubMedCrossRef Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol. 1998;105(8):836–48.PubMedCrossRef
29.
Zurück zum Zitat Steer PJ. The epidemiology of preterm labour—why have advances not equated to reduced incidence? BJOG. 2006;113(Suppl 3):1–3.PubMed Steer PJ. The epidemiology of preterm labour—why have advances not equated to reduced incidence? BJOG. 2006;113(Suppl 3):1–3.PubMed
30.
Zurück zum Zitat Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS. 2007;21(5):607–15. Mar 12.PubMedCrossRef Kourtis AP, Schmid CH, Jamieson DJ, Lau J. Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis. AIDS. 2007;21(5):607–15. Mar 12.PubMedCrossRef
31.
Zurück zum Zitat Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS. 2007;21(8):1019–26. May 11.PubMedCrossRef Townsend CL, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS. 2007;21(8):1019–26. May 11.PubMedCrossRef
32.
Zurück zum Zitat Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007(1):CD003510. Volmink J, Siegfried NL, van der Merwe L, Brocklehurst P. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2007(1):CD003510.
33.
Zurück zum Zitat Newman LA, Keckley C, Petersen MC, Hamner A. Swallowing function and medical diagnoses in infants suspected of Dysphagia. Pediatrics. 2001;108(6):E106.PubMedCrossRef Newman LA, Keckley C, Petersen MC, Hamner A. Swallowing function and medical diagnoses in infants suspected of Dysphagia. Pediatrics. 2001;108(6):E106.PubMedCrossRef
34.
Zurück zum Zitat Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369(9567):1107–16. Mar 31.PubMedCrossRef Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007;369(9567):1107–16. Mar 31.PubMedCrossRef
35.
Zurück zum Zitat Horvath T, Madi BC, Iuppa IM, et al. Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev. 2009(1):CD006734. Horvath T, Madi BC, Iuppa IM, et al. Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev. 2009(1):CD006734.
Metadaten
Titel
Conversations With Mothers: Exploring Reasons for Prevention of Mother-to-Child Transmission (PMTCT) Failures in the Era of Programmatic Scale-Up in Soweto, South Africa
verfasst von
Fatima Laher
Angela Cescon
Erica Lazarus
Angela Kaida
Matamela Makongoza
Robert S. Hogg
Christine N. Soon
Cari L. Miller
Glenda Gray
Publikationsdatum
01.01.2012
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2012
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-010-9875-9

Weitere Artikel der Ausgabe 1/2012

AIDS and Behavior 1/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.